Skip to main navigation Skip to search Skip to main content

IS THE USE OF LOW MOLECULAR WEIGHT HEPARIN IN BLOOD COMPATIBLE SURFACE COATINGS ADVANTAGEOUS OVER THAT OF NONFRACTIONATED HEPARIN?

  • W. E. Hennink*
  • , A. J.K. Knipmeijer
  • , G. H.M. Engbers
  • , L. Dost
  • , J. Feijen
  • *Corresponding author for this work
  • University of Twente

Research output: Contribution to conference › Paper › Academic

Abstract

Heparin fractions, which differ in molecular weight (2. 300 to 11. 100 D) and activity were coupled to human serum albumin. The activation of the intrinsic coagulation and the adhesion of blood platelets on materials coated with different albumin-heparin conjugates were studied. It was found that conjugates containing heparins with a molecular weight equal to or higher than 5000 D are very effective as coatings for improving the blood compatibility of surfaces with respect to both parameters tested. Conjugates with very low molecular weight heparin fragments (2000-3000 D) seem to be less effective, which might be ascribed to a strongly decreased interaction of heparin fragments with plasma proteins, which are necessary for expressing the anticoagulant activity of heparin and for reducing adverse heparin/platelet interactions.

Original languageEnglish
Pages7. 1-7. 11
Publication statusPublished - 1986
Externally publishedYes

Bibliographical note

Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.

Fingerprint

Dive into the research topics of 'IS THE USE OF LOW MOLECULAR WEIGHT HEPARIN IN BLOOD COMPATIBLE SURFACE COATINGS ADVANTAGEOUS OVER THAT OF NONFRACTIONATED HEPARIN?'. Together they form a unique fingerprint.

Cite this